Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.

by Kevin McLaughlin

Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.

by Ashley P. Taylor

A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.

by Jon Kelvey

The Cancer Today editorial staff selects some of the most interesting and impactful reporting, research and perspectives of 2018.

by Cancer Today Staff

Studies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.

by Kate Yandell

New research shows that rural cancer patients have the same health outcomes as urban cancer patients so long as they are involved in a clinical trial.

by Cheryl Platzman Weinstock

The recently passed Right to Try Act is meant to provide patients with greater access to experimental therapies. Patient advocates are divided on whether the law will benefit patients.

by Marci A. Landsmann

Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.

by Cici Zhang

A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non-small cell lung cancer treatment.

by Brad Jones

In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

by Brad Jones